Loading…
Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case Study
Neuroblastoma (NB) is the most common extra-cranial malignancy in preschool children. To portray the genetic landscape of an overly aggressive NB leading to a rapid clinical progression of the disease, tumor DNA collected pre- and post-treatment has been analyzed. Array comparative genomic hybridiza...
Saved in:
Published in: | Cells (Basel, Switzerland) Switzerland), 2021-10, Vol.10 (10), p.2695 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c481t-4aad4fabd07d53026d2ef8cc8a10af2718139e433f58348ad51c184087ea0cde3 |
---|---|
cites | cdi_FETCH-LOGICAL-c481t-4aad4fabd07d53026d2ef8cc8a10af2718139e433f58348ad51c184087ea0cde3 |
container_end_page | |
container_issue | 10 |
container_start_page | 2695 |
container_title | Cells (Basel, Switzerland) |
container_volume | 10 |
creator | Corallo, Diana Zanon, Carlo Pantile, Marcella Tonini, Gian Paolo Zin, Angelica Francescato, Samuela Rossi, Bartolomeo Trevisson, Eva Pinato, Claudia Monferrer, Ezequiel Noguera, Rosa Aliño, Salvador F Herrero, Maria Jose Biffi, Alessandra Viscardi, Elisabetta Aveic, Sanja |
description | Neuroblastoma (NB) is the most common extra-cranial malignancy in preschool children. To portray the genetic landscape of an overly aggressive NB leading to a rapid clinical progression of the disease, tumor DNA collected pre- and post-treatment has been analyzed. Array comparative genomic hybridization (aCGH), whole-exome sequencing (WES), and pharmacogenetics approaches, respectively, have identified relevant copy number alterations (CNAs), single nucleotide variants (SNVs), and polymorphisms (SNPs) that were then combined into an integrated analysis. Spontaneously formed 3D tumoroids obtained from the recurrent mass have also been characterized. The results prove the power of combining CNAs, SNVs, and SNPs analyses to assess clonal evolution during the disease progression by evidencing multiple clones at disease onset and dynamic genomic alterations during therapy administration. The proposed molecular and cytogenetic integrated analysis empowers the disease follow-up and the prediction of tumor recurrence. |
doi_str_mv | 10.3390/cells10102695 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_cea41b196d8a41d29832e914c9c1ba55</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_cea41b196d8a41d29832e914c9c1ba55</doaj_id><sourcerecordid>2584783021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-4aad4fabd07d53026d2ef8cc8a10af2718139e433f58348ad51c184087ea0cde3</originalsourceid><addsrcrecordid>eNpdkkFr3DAQRk1paUKaY69F0EsvTiRLsqUeCsuyTRZCe0hDj2IsjV0vXimV5IX993G6SchWFw3S4zHDN0XxkdELzjW9tDiOiVFGq1rLN8VpRRteCkH121f1SXGe0obOR7GaUfm-OOGiVrJuxGmBa5-xj5DRkeXV9eXv1S1ZeBj3CRNZuB14i-TOO4wpg3eD70noyKLvI6Y07JD8wCmGdoSUwxbIahfGKQ_BfyULsoSE5DZPbv-heNfBmPD86T4r7r6vfi2vy5ufV-vl4qa0QrFcCgAnOmgdbZzk81Cuwk5Zq4BR6KqGKcY1Cs47qbhQ4CSzTAmqGgRqHfKzYn3wugAbcx-HLcS9CTCYfw8h9gZiHuyIxiII1jJdOzUXrtKKV6iZsNqyFqScXd8Orvup3aKz6HOE8Uh6_OOHP6YPO6MkF5rVs-DLkyCGvxOmbLZDekwMPIYpmUoq0ah5TDajn_9DN2GKcwwHitdCN9VMlQfKxpBSxO6lGUbN4z6Yo32Y-U-vJ3ihn9PnDzZcsVM</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2584364972</pqid></control><display><type>article</type><title>Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case Study</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Corallo, Diana ; Zanon, Carlo ; Pantile, Marcella ; Tonini, Gian Paolo ; Zin, Angelica ; Francescato, Samuela ; Rossi, Bartolomeo ; Trevisson, Eva ; Pinato, Claudia ; Monferrer, Ezequiel ; Noguera, Rosa ; Aliño, Salvador F ; Herrero, Maria Jose ; Biffi, Alessandra ; Viscardi, Elisabetta ; Aveic, Sanja</creator><creatorcontrib>Corallo, Diana ; Zanon, Carlo ; Pantile, Marcella ; Tonini, Gian Paolo ; Zin, Angelica ; Francescato, Samuela ; Rossi, Bartolomeo ; Trevisson, Eva ; Pinato, Claudia ; Monferrer, Ezequiel ; Noguera, Rosa ; Aliño, Salvador F ; Herrero, Maria Jose ; Biffi, Alessandra ; Viscardi, Elisabetta ; Aveic, Sanja</creatorcontrib><description>Neuroblastoma (NB) is the most common extra-cranial malignancy in preschool children. To portray the genetic landscape of an overly aggressive NB leading to a rapid clinical progression of the disease, tumor DNA collected pre- and post-treatment has been analyzed. Array comparative genomic hybridization (aCGH), whole-exome sequencing (WES), and pharmacogenetics approaches, respectively, have identified relevant copy number alterations (CNAs), single nucleotide variants (SNVs), and polymorphisms (SNPs) that were then combined into an integrated analysis. Spontaneously formed 3D tumoroids obtained from the recurrent mass have also been characterized. The results prove the power of combining CNAs, SNVs, and SNPs analyses to assess clonal evolution during the disease progression by evidencing multiple clones at disease onset and dynamic genomic alterations during therapy administration. The proposed molecular and cytogenetic integrated analysis empowers the disease follow-up and the prediction of tumor recurrence.</description><identifier>ISSN: 2073-4409</identifier><identifier>EISSN: 2073-4409</identifier><identifier>DOI: 10.3390/cells10102695</identifier><identifier>PMID: 34685674</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>3D tumoroids ; array CGH ; Case Report ; Case studies ; Child, Preschool ; Chromosomes ; clonal evolution ; Comparative Genomic Hybridization ; Copy number ; Cytogenetics ; Disease Progression ; Drug Resistance, Neoplasm - genetics ; Evolution ; Exome Sequencing ; Fatal Outcome ; Genes ; Genomes ; Genomics ; Humans ; Hybridization ; Immunophenotyping ; Malignancy ; Medical prognosis ; Mutation ; Neuroblastoma ; Neuroblastoma - genetics ; Patients ; Pharmacogenetics ; Polymorphism, Single Nucleotide - genetics ; recurrent tumor ; Single-nucleotide polymorphism ; Software ; Tumors ; whole exome sequencing</subject><ispartof>Cells (Basel, Switzerland), 2021-10, Vol.10 (10), p.2695</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-4aad4fabd07d53026d2ef8cc8a10af2718139e433f58348ad51c184087ea0cde3</citedby><cites>FETCH-LOGICAL-c481t-4aad4fabd07d53026d2ef8cc8a10af2718139e433f58348ad51c184087ea0cde3</cites><orcidid>0000-0002-7104-273X ; 0000-0002-6042-4185 ; 0000-0002-3886-4360 ; 0000-0003-4546-7459 ; 0000-0002-5380-6265</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2584364972/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2584364972?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,74998</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34685674$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Corallo, Diana</creatorcontrib><creatorcontrib>Zanon, Carlo</creatorcontrib><creatorcontrib>Pantile, Marcella</creatorcontrib><creatorcontrib>Tonini, Gian Paolo</creatorcontrib><creatorcontrib>Zin, Angelica</creatorcontrib><creatorcontrib>Francescato, Samuela</creatorcontrib><creatorcontrib>Rossi, Bartolomeo</creatorcontrib><creatorcontrib>Trevisson, Eva</creatorcontrib><creatorcontrib>Pinato, Claudia</creatorcontrib><creatorcontrib>Monferrer, Ezequiel</creatorcontrib><creatorcontrib>Noguera, Rosa</creatorcontrib><creatorcontrib>Aliño, Salvador F</creatorcontrib><creatorcontrib>Herrero, Maria Jose</creatorcontrib><creatorcontrib>Biffi, Alessandra</creatorcontrib><creatorcontrib>Viscardi, Elisabetta</creatorcontrib><creatorcontrib>Aveic, Sanja</creatorcontrib><title>Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case Study</title><title>Cells (Basel, Switzerland)</title><addtitle>Cells</addtitle><description>Neuroblastoma (NB) is the most common extra-cranial malignancy in preschool children. To portray the genetic landscape of an overly aggressive NB leading to a rapid clinical progression of the disease, tumor DNA collected pre- and post-treatment has been analyzed. Array comparative genomic hybridization (aCGH), whole-exome sequencing (WES), and pharmacogenetics approaches, respectively, have identified relevant copy number alterations (CNAs), single nucleotide variants (SNVs), and polymorphisms (SNPs) that were then combined into an integrated analysis. Spontaneously formed 3D tumoroids obtained from the recurrent mass have also been characterized. The results prove the power of combining CNAs, SNVs, and SNPs analyses to assess clonal evolution during the disease progression by evidencing multiple clones at disease onset and dynamic genomic alterations during therapy administration. The proposed molecular and cytogenetic integrated analysis empowers the disease follow-up and the prediction of tumor recurrence.</description><subject>3D tumoroids</subject><subject>array CGH</subject><subject>Case Report</subject><subject>Case studies</subject><subject>Child, Preschool</subject><subject>Chromosomes</subject><subject>clonal evolution</subject><subject>Comparative Genomic Hybridization</subject><subject>Copy number</subject><subject>Cytogenetics</subject><subject>Disease Progression</subject><subject>Drug Resistance, Neoplasm - genetics</subject><subject>Evolution</subject><subject>Exome Sequencing</subject><subject>Fatal Outcome</subject><subject>Genes</subject><subject>Genomes</subject><subject>Genomics</subject><subject>Humans</subject><subject>Hybridization</subject><subject>Immunophenotyping</subject><subject>Malignancy</subject><subject>Medical prognosis</subject><subject>Mutation</subject><subject>Neuroblastoma</subject><subject>Neuroblastoma - genetics</subject><subject>Patients</subject><subject>Pharmacogenetics</subject><subject>Polymorphism, Single Nucleotide - genetics</subject><subject>recurrent tumor</subject><subject>Single-nucleotide polymorphism</subject><subject>Software</subject><subject>Tumors</subject><subject>whole exome sequencing</subject><issn>2073-4409</issn><issn>2073-4409</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkkFr3DAQRk1paUKaY69F0EsvTiRLsqUeCsuyTRZCe0hDj2IsjV0vXimV5IX993G6SchWFw3S4zHDN0XxkdELzjW9tDiOiVFGq1rLN8VpRRteCkH121f1SXGe0obOR7GaUfm-OOGiVrJuxGmBa5-xj5DRkeXV9eXv1S1ZeBj3CRNZuB14i-TOO4wpg3eD70noyKLvI6Y07JD8wCmGdoSUwxbIahfGKQ_BfyULsoSE5DZPbv-heNfBmPD86T4r7r6vfi2vy5ufV-vl4qa0QrFcCgAnOmgdbZzk81Cuwk5Zq4BR6KqGKcY1Cs47qbhQ4CSzTAmqGgRqHfKzYn3wugAbcx-HLcS9CTCYfw8h9gZiHuyIxiII1jJdOzUXrtKKV6iZsNqyFqScXd8Orvup3aKz6HOE8Uh6_OOHP6YPO6MkF5rVs-DLkyCGvxOmbLZDekwMPIYpmUoq0ah5TDajn_9DN2GKcwwHitdCN9VMlQfKxpBSxO6lGUbN4z6Yo32Y-U-vJ3ihn9PnDzZcsVM</recordid><startdate>20211009</startdate><enddate>20211009</enddate><creator>Corallo, Diana</creator><creator>Zanon, Carlo</creator><creator>Pantile, Marcella</creator><creator>Tonini, Gian Paolo</creator><creator>Zin, Angelica</creator><creator>Francescato, Samuela</creator><creator>Rossi, Bartolomeo</creator><creator>Trevisson, Eva</creator><creator>Pinato, Claudia</creator><creator>Monferrer, Ezequiel</creator><creator>Noguera, Rosa</creator><creator>Aliño, Salvador F</creator><creator>Herrero, Maria Jose</creator><creator>Biffi, Alessandra</creator><creator>Viscardi, Elisabetta</creator><creator>Aveic, Sanja</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-7104-273X</orcidid><orcidid>https://orcid.org/0000-0002-6042-4185</orcidid><orcidid>https://orcid.org/0000-0002-3886-4360</orcidid><orcidid>https://orcid.org/0000-0003-4546-7459</orcidid><orcidid>https://orcid.org/0000-0002-5380-6265</orcidid></search><sort><creationdate>20211009</creationdate><title>Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case Study</title><author>Corallo, Diana ; Zanon, Carlo ; Pantile, Marcella ; Tonini, Gian Paolo ; Zin, Angelica ; Francescato, Samuela ; Rossi, Bartolomeo ; Trevisson, Eva ; Pinato, Claudia ; Monferrer, Ezequiel ; Noguera, Rosa ; Aliño, Salvador F ; Herrero, Maria Jose ; Biffi, Alessandra ; Viscardi, Elisabetta ; Aveic, Sanja</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-4aad4fabd07d53026d2ef8cc8a10af2718139e433f58348ad51c184087ea0cde3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>3D tumoroids</topic><topic>array CGH</topic><topic>Case Report</topic><topic>Case studies</topic><topic>Child, Preschool</topic><topic>Chromosomes</topic><topic>clonal evolution</topic><topic>Comparative Genomic Hybridization</topic><topic>Copy number</topic><topic>Cytogenetics</topic><topic>Disease Progression</topic><topic>Drug Resistance, Neoplasm - genetics</topic><topic>Evolution</topic><topic>Exome Sequencing</topic><topic>Fatal Outcome</topic><topic>Genes</topic><topic>Genomes</topic><topic>Genomics</topic><topic>Humans</topic><topic>Hybridization</topic><topic>Immunophenotyping</topic><topic>Malignancy</topic><topic>Medical prognosis</topic><topic>Mutation</topic><topic>Neuroblastoma</topic><topic>Neuroblastoma - genetics</topic><topic>Patients</topic><topic>Pharmacogenetics</topic><topic>Polymorphism, Single Nucleotide - genetics</topic><topic>recurrent tumor</topic><topic>Single-nucleotide polymorphism</topic><topic>Software</topic><topic>Tumors</topic><topic>whole exome sequencing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Corallo, Diana</creatorcontrib><creatorcontrib>Zanon, Carlo</creatorcontrib><creatorcontrib>Pantile, Marcella</creatorcontrib><creatorcontrib>Tonini, Gian Paolo</creatorcontrib><creatorcontrib>Zin, Angelica</creatorcontrib><creatorcontrib>Francescato, Samuela</creatorcontrib><creatorcontrib>Rossi, Bartolomeo</creatorcontrib><creatorcontrib>Trevisson, Eva</creatorcontrib><creatorcontrib>Pinato, Claudia</creatorcontrib><creatorcontrib>Monferrer, Ezequiel</creatorcontrib><creatorcontrib>Noguera, Rosa</creatorcontrib><creatorcontrib>Aliño, Salvador F</creatorcontrib><creatorcontrib>Herrero, Maria Jose</creatorcontrib><creatorcontrib>Biffi, Alessandra</creatorcontrib><creatorcontrib>Viscardi, Elisabetta</creatorcontrib><creatorcontrib>Aveic, Sanja</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>Biological Sciences</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Cells (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Corallo, Diana</au><au>Zanon, Carlo</au><au>Pantile, Marcella</au><au>Tonini, Gian Paolo</au><au>Zin, Angelica</au><au>Francescato, Samuela</au><au>Rossi, Bartolomeo</au><au>Trevisson, Eva</au><au>Pinato, Claudia</au><au>Monferrer, Ezequiel</au><au>Noguera, Rosa</au><au>Aliño, Salvador F</au><au>Herrero, Maria Jose</au><au>Biffi, Alessandra</au><au>Viscardi, Elisabetta</au><au>Aveic, Sanja</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case Study</atitle><jtitle>Cells (Basel, Switzerland)</jtitle><addtitle>Cells</addtitle><date>2021-10-09</date><risdate>2021</risdate><volume>10</volume><issue>10</issue><spage>2695</spage><pages>2695-</pages><issn>2073-4409</issn><eissn>2073-4409</eissn><abstract>Neuroblastoma (NB) is the most common extra-cranial malignancy in preschool children. To portray the genetic landscape of an overly aggressive NB leading to a rapid clinical progression of the disease, tumor DNA collected pre- and post-treatment has been analyzed. Array comparative genomic hybridization (aCGH), whole-exome sequencing (WES), and pharmacogenetics approaches, respectively, have identified relevant copy number alterations (CNAs), single nucleotide variants (SNVs), and polymorphisms (SNPs) that were then combined into an integrated analysis. Spontaneously formed 3D tumoroids obtained from the recurrent mass have also been characterized. The results prove the power of combining CNAs, SNVs, and SNPs analyses to assess clonal evolution during the disease progression by evidencing multiple clones at disease onset and dynamic genomic alterations during therapy administration. The proposed molecular and cytogenetic integrated analysis empowers the disease follow-up and the prediction of tumor recurrence.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>34685674</pmid><doi>10.3390/cells10102695</doi><orcidid>https://orcid.org/0000-0002-7104-273X</orcidid><orcidid>https://orcid.org/0000-0002-6042-4185</orcidid><orcidid>https://orcid.org/0000-0002-3886-4360</orcidid><orcidid>https://orcid.org/0000-0003-4546-7459</orcidid><orcidid>https://orcid.org/0000-0002-5380-6265</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2073-4409 |
ispartof | Cells (Basel, Switzerland), 2021-10, Vol.10 (10), p.2695 |
issn | 2073-4409 2073-4409 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_cea41b196d8a41d29832e914c9c1ba55 |
source | Publicly Available Content (ProQuest); PubMed Central |
subjects | 3D tumoroids array CGH Case Report Case studies Child, Preschool Chromosomes clonal evolution Comparative Genomic Hybridization Copy number Cytogenetics Disease Progression Drug Resistance, Neoplasm - genetics Evolution Exome Sequencing Fatal Outcome Genes Genomes Genomics Humans Hybridization Immunophenotyping Malignancy Medical prognosis Mutation Neuroblastoma Neuroblastoma - genetics Patients Pharmacogenetics Polymorphism, Single Nucleotide - genetics recurrent tumor Single-nucleotide polymorphism Software Tumors whole exome sequencing |
title | Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case Study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T20%3A39%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Integrated%20CGH/WES%20Analyses%20Advance%20Understanding%20of%20Aggressive%20Neuroblastoma%20Evolution:%20A%20Case%20Study&rft.jtitle=Cells%20(Basel,%20Switzerland)&rft.au=Corallo,%20Diana&rft.date=2021-10-09&rft.volume=10&rft.issue=10&rft.spage=2695&rft.pages=2695-&rft.issn=2073-4409&rft.eissn=2073-4409&rft_id=info:doi/10.3390/cells10102695&rft_dat=%3Cproquest_doaj_%3E2584783021%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c481t-4aad4fabd07d53026d2ef8cc8a10af2718139e433f58348ad51c184087ea0cde3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2584364972&rft_id=info:pmid/34685674&rfr_iscdi=true |